Compile Data Set for Download or QSAR
Report error Found 143 Enz. Inhib. hit(s) with all data for entry = 7558
TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202409(US9238644, 16)
Affinity DataIC50: 1nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202417(US9238644, 24)
Affinity DataIC50: 2nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202411(US9238644, 18)
Affinity DataIC50: 3nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202412(US9238644, 19)
Affinity DataIC50: 3nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202440(US9238644, 45)
Affinity DataIC50: 3nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202463(US9238644, 65)
Affinity DataIC50: 3nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202476(US9238644, 77)
Affinity DataIC50: 3nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202406(US9238644, 13)
Affinity DataIC50: 4nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202424(US9238644, 30)
Affinity DataIC50: 4nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202475(US9238644, 76)
Affinity DataIC50: 4nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202409(US9238644, 16)
Affinity DataIC50: 4nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202442(US9238644, 47)
Affinity DataIC50: 5nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202411(US9238644, 18)
Affinity DataIC50: 5nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202407(US9238644, 14)
Affinity DataIC50: 6nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202413(US9238644, 20)
Affinity DataIC50: 7nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202414(US9238644, 21)
Affinity DataIC50: 7nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202419(US9238644, 25)
Affinity DataIC50: 7nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202428(US9238644, 34)
Affinity DataIC50: 7nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202464(US9238644, 66)
Affinity DataIC50: 7nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202465(US9238644, 67)
Affinity DataIC50: 7nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202399(US9238644, 6)
Affinity DataIC50: 8nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202423(US9238644, 29)
Affinity DataIC50: 8nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202462(US9238644, 64)
Affinity DataIC50: 8nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202396(US9238644, 3)
Affinity DataIC50: 9nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202410(US9238644, 17)
Affinity DataIC50: 9nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202429(US9238644, 35)
Affinity DataIC50: 9nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202438(US9238644, 44)
Affinity DataIC50: 9nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202406(US9238644, 13)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202395(US9238644, 2)
Affinity DataIC50: 10nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202400(US9238644, 7)
Affinity DataIC50: 10nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202401(US9238644, 8)
Affinity DataIC50: 10nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202470(US9238644, 71)
Affinity DataIC50: 10nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202408(US9238644, 15)
Affinity DataIC50: 11nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202416(US9238644, 23)
Affinity DataIC50: 11nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202412(US9238644, 19)
Affinity DataIC50: 11nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202420(US9238644, 26)
Affinity DataIC50: 12nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202437(US9238644, 43)
Affinity DataIC50: 12nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202443(US9238644, 48)
Affinity DataIC50: 12nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202441(US9238644, 46)
Affinity DataIC50: 13nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202418(US9238644, 24A)
Affinity DataIC50: 14nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202414(US9238644, 21)
Affinity DataIC50: 14nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202446(US9238644, 51)
Affinity DataIC50: 15nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202451(US9238644, 55)
Affinity DataIC50: 15nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202430(US9238644, 36)
Affinity DataIC50: 16nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202450(US9238644, 54)
Affinity DataIC50: 17nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202399(US9238644, 6)
Affinity DataIC50: 17nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202401(US9238644, 8)
Affinity DataIC50: 19nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202455(US9238644, 57-2A)
Affinity DataIC50: 19nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202415(US9238644, 22)
Affinity DataIC50: 20nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202411(US9238644, 18)
Affinity DataIC50: 21nMpH: 7.2 T: 2°CAssay Description:Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Gre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
Go to US Patent

Displayed 1 to 50 (of 143 total ) | Next | Last >>
Jump to: